Dystrophin or a "related protein" in Duchenne muscular dystrophy?

Area of Science:

• Biochemistry
• Genetics
• Neuromuscular Disorders

Background:

• Duchenne muscular dystrophy (DMD) is characterized by low dystrophin levels.
• The "frame-shift hypothesis" suggests DMD muscle lacks C-terminal dystrophin, proposing detected protein is an autosomal homologue.

Purpose of the Study:

• To determine if the detected dystrophin in DMD muscle is Xp21-encoded dystrophin or an autosomal homologue.
• To clarify the nature of dystrophin expression in DMD for improved interpretation of therapeutic strategies.

Main Methods:

• Serial sections of DMD muscle were labeled using specific monoclonal antibodies targeting the amino, rod, and C-terminal domains of dystrophin.
• Immunohistochemical analysis was performed to assess the localization and presence of dystrophin on individual muscle fibers.

Main Results:

• Antibody labeling for all three dystrophin domains (amino, rod, C-terminal) occurred on the same individual muscle fibers in DMD samples.
• The abundance of "C-terminal dystrophin" was observed to be lower than "rod dystrophin" in both Becker muscular dystrophy (BMD) and DMD muscle samples when analyzed by blotting.

Conclusions:

• The protein detected in DMD muscle is confirmed to be Xp21-encoded dystrophin, refuting the autosomal homologue hypothesis.
• These findings necessitate a re-evaluation of myoblast transfer experiments and highlight differences in domain-specific dystrophin abundance in dystrophinopathies.